Search

Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study

Trial Phase 3 Completed Nov. 6, 2019

Pilot Trial of Transnasal Nicotine in Parkinson Disease

Trial Phase 2 Completed Nov. 5, 2019

A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

Trial Phase 2 Completed Nov. 5, 2019

Diagnostic Tools for Parkinson's Disease

Trial N/A Completed Nov. 3, 2019

Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease

Trial Phase 1 Completed Oct. 31, 2019

7T MRS in Parkinson's Disease

Trial N/A Completed Oct. 31, 2019

Functional Connectivity Parkinson Disease

Trial N/A Completed Oct. 31, 2019

Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes

Trial N/A Completed Oct. 31, 2019

Video Based Mindfulness Based Stress Reduction

Trial N/A Completed Oct. 30, 2019

Learning Effective New Strategies for Worry in Parkinson's Disease

Trial N/A Unknown Oct. 30, 2019

Transcranial Direct Current Stimulation (tDCS) and Parkinson's Disease

Trial N/A Completed Oct. 29, 2019

Helicobacter Pylori Eradication Study in Parkinson's Disease

Trial N/A Completed Oct. 29, 2019

Trial of Probiotics for Constipation in Parkinson's Disease

Trial N/A Completed Oct. 29, 2019

Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease

Trial Phase 2 Completed Oct. 28, 2019

Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease

Trial Phase 1 Completed Oct. 28, 2019

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Trial Phase 3 Completed Oct. 28, 2019

Patient-Centered PD Ambulatory Monitoring System

Trial N/A Unknown Oct. 28, 2019

Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)

Trial Phase 2 Unknown Oct. 28, 2019

Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease

Trial Phase 2 Completed Oct. 28, 2019

A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease

Trial Phase 3 Completed Oct. 28, 2019